There is new, winning technology coming to the market that is easier to use than a smartphone, adaptive, completely wireless, and fully controllable by users. Shacey Petrovic is the CEO of Insulet, an innovative medical device company making the lives of people with diabetes easier through the use of its Omnipod product platform. Shacey has a strong background in med tech and life sciences, but also takes the diabetes market by storm with her skills in commercial leadership, sales, marketing, and 'put the patient first' mentality.

An incredible individual, I can’t wait for us to dive in and learn from Shacey how she is bringing innovation to the market with tubeless Omnipod technology.

[00:01 - 03:15 ] Opening Segment

• I introduce Shacey 
• Shacey’s background and experience
• Med tech and business background 
• Working in women’s health 
• Recruited to Insulet 
• Synergies between diabetes and women’s health care
• The challenges and rewards
• The shock of industry dynamics drive rather than patient welfare

[03:16 - 15:20 ]  Bringing Innovation to the Market with Tubeless Omnipod Technology

• Differences from the conventional insulin pump model
• Getting better outcomes for patients
• Why so many are converting to MDI
• Better control 
• Reducing burden 
• Great to be wireless/tubeless 
• Shacey talks about the Omnipod 5 and its features 
• What makes it transformative 
• The first tubeless insulin delivery
• Controlled via smartphone 
• Adaptive features 
• FDA support
• Forward leaning with diabetes innovation 
• Shacey’s thoughts on prefilled cartridge delivery 

[15:21 - 23:58 ] How Omnipod 5 Navigates the Digital Market

• Shacey talks about Insulet and the Insulin industry
• Getting people broader access 
• Reducing burden for users 
• Thoughts on entering the Amazon marketplace
• The benefit of working with co-pays over deductibles 
• Predictable and affordable 
• Shacey shares about the drug delivery system
• Strategic partnerships 
• A wave of innovation in the market
• Navigating the new challenges in the market
• Telehealth and virtual training 
• Balancing in-person with at-home
• How Omnipod 5 takes on the new challenges

[23:59 - 29:48 ] Closing Segment

• Let’s talk five to seven years out 
• The launch of Omnipod 5
• CGM data in the works
• Only simple and effective solutions
• Shacey’s projections on insulin
• Exciting things in the pipeline
• The dynamics of running a public company
• Play to win not to survive
• Technology is outpacing the health machine complex
• We’re all in this together
• The introduction of utilizing people’s information
• Final Words 

Tweetable Quotes:

“All of our users and what my team is excited about is that this will really leapfrog the market. It will be the first fully wearable, wireless or ‘tubeless’ automated insulin delivery.” - Shacey Petrovic

“Everybody wants better control, but most people don't want to work harder. So if we can help them get better control without having to work hard for it, that's a winning combination.” - Shacey Petrovic

“There's this innovation and technology adoption wave happening in diabetes, and we're investing to capture that.” - Shacey Petrovic

Connect with Shacey on LinkedIn. Go check out https://insulet.com/ and learn more about their groundbreaking insulin management technology.

To know more, you can connect with me, David Kliff on Facebook, Twitter, and LinkedIn, or email me at dkliff@diabeticinvestor.com. Be sure to visit https://diabeticinvestor.com for more insights and real-time analyses on the evolving business of diabetes.

Don’t be shy, I’d love to hear from you! You can also reach me at 224-715-3761.

NOTE*: We are in no way a replacement for real medical professionals. All information in this podcast is obtained through reliable sources. Please be aware of our Disclaimer.

LEAVE, SUBSCRIBE, REVIEW + help someone who wants to learn more about the wacky world of diabetes and everything happening within it.